Skip to main content
Premium Trial:

Request an Annual Quote

Biomatrica Wins $1M Grant to Create Biobank Prototype for US Army

NEW YORK (GenomeWeb) – Biomatrica has received a $1 million grant to develop a blueprint and functional prototype of an ambient temperature biobank for the US Army.

The San Diego-based biostabilization technology developer said yesterday it will use the Small Business Innovation Research award to create a biobank that will be able to store biological samples from 1 million service members. The biobank, which Biomatrica said will be the largest of its type in the world, will contain DNA and RNA samples extracted from blood, and it will be structured in modular units to facilitate global deployment of samples.

Biomatrica said the biobank will be built upon its ambient temperature biostabilization technologies, including the RNAgard Blood, DNAgard Saliva, RNAstable, and DNAstable Plus reagents.

"Full automation, from DNA and RNA extraction, to storage, archiving and retrieval, will enable a highly efficient workflow capable of processing hundreds of samples per day," Biomatrica CEO Judy Muller-Cohn said in a statement.

The company will store the samples in its ambient temperature dry storage cabinets, and it will use its SampleWare lab information system to manage data related to the samples.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.